Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obatoclax in Myelofibrosis
NCT00360035Phase 2Completed
- Sponsor
- Gemin X Pharmaceuticals
- Start
- Jul 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of obatoclax in myelofibrosis (MF), sponsored by Gemin X Pharmaceuticals. Started Jul 2006; status: completed.
02
Drugs
obatoclax
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00360035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360035.